Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LLY
NVO
Add up to 3 more stocks
LLY
Eli Lilly and Company
+0.65%
$1,143.55+7.44Delayed quote: Sep 16, 2026, 11:15 AM EDT
Market Cap
$1.08T
52W Range
$712.05 - $1,292.65
NVO
Novo Nordisk A/S
-1.06%
$42.08-0.45Delayed quote: Sep 16, 2026, 11:15 AM EDT
Market Cap
$186.86B
52W Range
$35.12 - $64.16
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 38.37 | 10.37 |
| Forward P/E | 31.42 | N/A |
| P/B Ratio | 31.79 | 5.54 |
| P/S Ratio | 13.52 | 3.66 |
| P/FCF Ratio | 53.70 | 25.09 |
| EV/EBITDA | 30.64 | 7.68 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 84.0% | 80.6% |
| Operating Margin | 43.9% | 43.1% |
| Net Margin | 33.5% | 35.3% |
| ROE | 78.8% | 53.5% |
| ROA | 18.8% | 19.9% |
| ROIC | 27.4% | 30.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 0.87 |
| Quick Ratio | 1.00 | 0.66 |
| Debt/Equity | 1.62 | 0.63 |
| Interest Coverage | 37.34 | 30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.6% | 4.2% |
| Payout Ratio | 22.4% | 44.3% |
| Yrs of Dividend Growth | 11 | 6 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.